Full Press Release Details
PITTSBURGH , Dec. 14, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ), a global healthcare company, today announced that its near-term science-based emissions reduction targets have been approved by the Science Based Targets initiative (SBTi). SBTi is a global body enabling businesses to set ambitious emissions reduction targets in line with the latest climate science.
Viatris President Rajiv Malik said, "This approval from SBTi marks an important milestone in Viatris' ongoing commitment to sustainable operations. We monitor our progress regularly, evaluating greenhouse gas reductions and emission reduction strategies annually. We are committed to minimizing our impact on the environment while safeguarding a reliable supply of medicine."
Viatris announced its initial companywide sustainability goals, including environmental targets, earlier this year. The SBTi classified Viatris' scope 1 and 2 target ambition and has determined that it is in line with a 1.5°C trajectory, a worldwide goal of limiting global warming. The company's climate targets are:
These efforts include systematic work to reduce carbon emissions, increasing the use of renewable energy, enhancing efficiency in our own operations and working with partners to encourage their efforts. We are also working to protect our employees and operations from the impact of climate change through effective planning, risk mitigation and building resilience against the impact of extreme weather and providing or deploying appropriate technologies and processes that ensure minimal impact on the climate.
Viatris Head of Corporate Affairs Lara Ramsburg said, "Through our dedicated and passionate global workforce, Viatris is making important progress on the targets validated by SBTi which support our commitment to sustainably providing access to high-quality medicines. Since environmental and human health are interconnected, climate change mitigation and adaptation are key components of protecting the resiliency of our supply chain, the health and well-being of patients we serve and the communities on which we depend."
SBTi is a partnership between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF). The SBTi call to action is one of the We Mean Business Coalition commitments. The initiative defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption and independently assesses and approves companies' targets.
As a global healthcare company, sustainability is at the core of Viatris' business and purpose. To learn more about Viatris' efforts and how the company is partnering with stakeholders throughout the globe to address some of the world's most pressing health, environmental and social issues, please read the company's 2021 Sustainability Report , which outlines the company's 2021 progress, achievements and commitments across key areas including access and global health, employees, environmental stewardship and community engagement.
About Viatris Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 , Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on Twitter at @ViatrisInc , LinkedIn and YouTube .
SOURCE Viatris Inc.